Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

Gladman, DD, Orbai, A-M, Klitz, U et al. (6 more authors) (2019) Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis. Arthritis Research and Therapy, 21. ARTN 38. ISSN 1478-6354

Metadata

Authors/Creators:
  • Gladman, DD
  • Orbai, A-M
  • Klitz, U
  • Wei, JC-C
  • Gallo, G
  • Birt, J
  • Rathmann, S
  • Shrom, D
  • Marzo-Ortega, H
Copyright, Publisher and Additional Information: © The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated
Keywords: Ixekizumab; Enthesitis; Dactylitis; Psoriatic arthritis
Dates:
  • Published: 29 January 2019
  • Accepted: 18 January 2019
  • Published (online): 29 January 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Jun 2019 11:22
Last Modified: 14 Jun 2019 11:22
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/s13075-019-1831-0
Related URLs:

Share / Export

Statistics